CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 7 No. 9
 

NIH Expert Dispels Myths About Genetic Counseling

September 1, 1998

BALTIMORE--"Genetic testing may soon become another routine tool of medicine," Barbara Biesecker, MS, said at a Johns Hopkins conference on genetic testing for adult onset disorders. Making genetic testing routine will require training more professionals in genetic counseling and overcoming a number of myths that have accumulated around the field, said Ms. Biesecker, co-director of the Genetic Counseling Research and Training Program of the NIH’s Medical Genetics Branch.

Myth #1: Genetic counseling is simply an educational process--the provision of risk information to a client. In fact, Ms. Biesecker said, genetic counselors should be ready to explore the deeper meaning of the genetic information with patients and their families. Health care providers, for example, may tend to hear and answer the concrete questions patients ask while missing the emotional anxiety lying below the surface.

"Genetic counseling grew out of a medical model that has now evolved to encompass a psychosocial component," she said. "In some ways, it’s like short-term psychotherapy, and in some ways, it’s an educational process."

Myth #2: All clients will readily understand and retain the information presented. In reality, patients’ knowledge and comprehension of genetic testing and its results vary greatly. Ms. Biesecker recalled the case of one patient who, after listening to a detailed explanation of a genetic test, asked, "What’s a cell?"

In another case, a mother was concerned about her child’s bronchitis only to slowly realize that the counselor was talking about fragile-X syndrome.

Patients’ personal beliefs may further complicate their understanding of the test results presented. A woman being tested for a BRCA1 mutation may say to herself, "I look just like my mom, so I guess I’ll get breast cancer, too."

Myth #3: Clients will base important decisions like childbearing on statistical expressions of risk. In fact, she said, for some families, the burden of risk may be far more important than the percentages. For a family already caring for a child with congenital heart disease, for example, a 2% risk of the same ailment in future offspring may carry more weight than a 50% chance of some other disorder.

Is It Always Better to Know?

Myth #4: It is always "better to know." This myth is contradicted by the reality that people react differently to genetic information. Some patients really do want to know what their genes have in store for them, but others do not.

"Positive genetic test results," Ms. Biesecker said, "are not always the worst thing in the world, and negative results are not necessarily unadulterated good news, since other family members may not be spared."

Myth #5: Genetic information is always straightforward in its meaning. In reality, complicated tests and results are sometimes subject to ambiguity and interpretation. Thus, neither counselors nor physicians should make assumptions about the meaning of a test result or a medical condition to a patient.

Counselors must take their own biases into consideration. Since some diseases (like cystic fibrosis) are highly variable in their expression, genetic counselors must be careful not to over-interpret test results. Also, many hereditary disorders are "moving targets," with medical advances rapidly changing the outlook for prevention and treatment. Cystic fibrosis patients, for example, have more options and fewer limitations than they did 30 years ago.

Cultural values may subtly skew interpretation, too, given that 97% of all genetic counselors are young, white, and female. "The field can use more diversity to deal with a diverse patient population," Ms. Biesecker said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy